Based on research conducted at UMass Medical School, TNX-4800 is a long-acting monoclonal antibody now being licensed to Tonix Pharmaceuticals for further development as single-dose, seasonal protecti...
GLA’s Chief Scientific Officer featured on BBC’s The Inquiry podcast, discussing global rise in Lyme disease and new developments in the field. Global Lyme Alliance’s Chief Scientific Officer, Dr. Arm...
GLA participates in ICLB 2025, joining international experts to share insights and highlight advances in Lyme and tick-borne disease research. Every year, GLA’s science team attends major conferences ...
Dear Friends & Supporters,
by Dr. Armin Alaedini, GLA Chief Scientific Officer, & Dr. Cara DeAngelis, Director of Research at Global Lyme Alliance